Epileptic Seizures Under Antidepressive Drug Treatment: Systematic Review

Abstract

Objective This paper is a systematic review on seizures under treatment with substances licensed for major depression.

Method Systematic review protocol is available in PROSPERO registration number CRD42016034010. Twenty-five substances were selected according to frequencies of prescriptions and publications. A PubMed search was conducted with “substance name” and “seizure.”

Results A total of 2291 articles were screened, out of which 164 fulfilled inclusion criteria. Data synthesis was possible only to a limited extent due to heterogeneity of included patients, observation periods, methods, and outcomes. Evidence for an at most moderate, but still low, risk (>0.1% under regular doses) was found highest for clomipramine, followed by quetiapine, amitriptyline, venlafaxine, citalopram, sertraline, trazodone, mirtazapine, paroxetine, bupropion, and escitalopram. For fluoxetine and duloxetine, the risk seems to be negligible. For the other, mostly newer, substances, sufficient evidence was not available. An increased risk for lithium, as reported in many reviews and textbooks, could not be confirmed.

Conclusions Antidepressive treatment is rather safe in terms of risk of seizures and also can be generally recommended in the treatment of patients with epilepsy.

Key words

seizure - epilepsy - antidepressant - lithium - review

• References

• 1 Kanner AM. The treatment of depressive disorders in epilepsy: what all neurologists should know. Epilepsia 2013; 54 (Suppl. 01) 3-12
• 2 Engel Jr J. International League Against Epilepsy (ILAE). A proposed diagnostic scheme for people with epileptic seizures and with epilepsy. Report of the ILAE task force on classification and terminology. Epilepsia 2001; 46: 796-803
• 3 Fisher RS, Acevedo C, Arzimanoglou A. et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014; 55: 475-482
• 4 Fröscher W. Akute symptomatische Epilepsien und Gelegenheitsanfälle des Erwachsenenalters. In: Fröscher W, Vassella F, Hufnagel A. (eds.) Die Epilepsien. 2. Aufl. Stuttgart, New York: Schattauer; 2004: 220-223
• 5 Bast T, Carmant L. Febrile and other occasional seizures. In: Dulac O, Lassonde M, Sarnat HB. (eds.) Handbook of Clinical Neurology. vol. 111 3rd series Edinburgh: Elsevier; 2013: 477-491
• 6 Meyer A, Froescher W. Anfallssteigernde Medikamente und Drogen. In: Fröscher W, Vassella F, Hufnagel A. (eds.) Die Epilepsien. 2. Aufl. Stuttgart, New York: Schattauer; 2004: 523-541
• 7 Berg AT, Berkovic SF, Brodie MJ. et al. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology. Epilepsia 2010; 51: 676-685
• 8 Berg A, Cross JH. Classification of epilepsies and seizures: Historical perspective and future directions. In Stefan H, Theodore WH. (eds.) Handbook of Clinical Neurology. vol. 107 3rd series Epilepsy, Part I. Edinburgh: Elsevier; 2012: 99-111
• 9 Garcia PA, Alldredge BK. Drug-induced seizures. Neurol Clin. 1994; 12: 85-99
• 10 European College of Neuropsychopharmacology . Neuroscience based nomenclature. 1st ed. Cambridge: Cambridge University Press; 2014
• 11 University of York: Centre of Reviews and Dissemination. International register of systematic reviews. http://www.crd.york.ac.uk/PROSPERO/ Accessed on April 5, 2016
• 12 Eyding D, Lelgemann M, Grouven U. et al. Reboxetine for acute treatment of major depression: Systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ 2010; 341: c4737
• 13 Dastgheib M, Moezi L. Acute and chronic effects of agomelatine on intravenous penthylenetetrazol-induced seizure in mice and the probable role of nitric oxide. Eur J Pharmacol. 2014; 736: 10-15
• 14 Aguiar CC, Almeida AB, Araújo PV. et al. Anticonvulsant effects of agomelatine in mice. Epilepsy Behav. 2012; 24: 324-328
• 15 Kleinrok Z, Gustaw J, Czuczwar SJ. Influence of antidepressant drugs on seizure susceptibility and the anticonvulsant activity of valproate in mice. J Neural Transm Suppl. 1991; 34: 85-90
• 16 Clifford DB, Rutherford JL, Hicks FG. et al. Acute effects of antidepressants on hippocampal seizures. Ann Neurol. 1985; 18: 692-697
• 17 Reichert C, Reichert P, Monnet-Tschudi F. et al. Seizures after single-agent overdose with pharmaceutical drugs: Analysis of cases reported to a poison center. Clin Toxicol (Phila) 2014; 52: 629-634
• 18 Paksu S, Duran L, Altuntas MA. et al. Amitriptyline overdose in emergency department of university hospital: evaluation of 250 patients. Hum Exp Toxicol. 2014; 33: 980-990
• 19 Güloglu C, Orak M, Ustündag M. et al. Analysis of amitriptyline overdose in emergency medicine. Emerg Med J. 2011; 28: 296-299
• 20 Pedersen OL, Gram LF, Kristensen CB. et al. Overdosage of antidepressants: Clinical and pharmacokinetic aspects. Eur J Clin Pharmacol. 1982; 23: 513-521
• 21 Crome P, Newman B. The problem of tricyclic antidepressant poisoning. Postgrad Med J. 1979; 55: 528-532
• 22 Köppel C, Wiegreffe A, Tenczer J. Clinical course, therapy, outcome and analytical data in amitriptyline and combined amitriptyline/chlordiazepoxide overdose. Hum Exp Toxicol. 1992; 11: 458-465
• 23 Zhu Y, Zhang X. Analysis of 20 cases of amitriptyline poisoning. Zhonghua Shen Jing Jing Shen Ke Za Zhi 1992; 25: 13-15
• 24 Olgun H, Yildirim ZK, Karacan M. et al. Clinical, electrocardiographic, and laboratory findings in children with amitriptyline intoxication. Pediatr Emerg Care. 2009; 25: 170-173
• 25 Agelink MW, Ullrich H, Passenberg P. et al. Superior safety of reboxetine over amitriptyline in the elderly. Eur J Med Res. 2002; 7: 415-416
• 26 Kumlien E, Lundberg PO. Seizure risk associated with neuroactive drugs: Data from the WHO adverse drug reactions database. Seizure 2010; 19: 69-73
• 27 Coupland C, Dhiman P, Morriss R. et al. Antidepressant use and risk of adverse outcomes in older people: Population based cohort study. BMJ 2011; 343: d4551
• 28 Lowry MR, Dunner FJ. Seizures during tricyclic therapy. Am J Psychiatry. 1980; 137: 1461-1462
• 29 Avoni P, Riva R, Albani F. Recurrence of absence seizures induced by a low dose of amitriptyline: a case report. Eur J Neurol 1996; 3: 272-274
• 30 Houghton AW. Convulsions precipitated by amitriptyline. Lancet 1971; 1: 138
• 31 Tutka P, Barczynski B, Wielosz M. Convulsant and anticonvulsant effects of bupropion in mice. Eur J Pharmacol. 2004; 499: 117-120
• 32 Vermoesen K, Serruys AS, Loyens E. et al. Assessment of the convulsant liability of antidepressants using zebrafish and mouse seizure models. Epilepsy Behav. 2011; 22: 450-460
• 33 Ahern TH, Javors MA, Eagles DA. et al. The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice. Neuropsychopharmacology 2006; 31: 730-738
• 34 Finkelstein Y, Hutson JR, Freedman SB. et al. Toxicology Investigators Consortium. Drug-induced seizures in children and adolescents presenting for emergency care: Current and emerging trends. Clin Toxicol (Phila) 2013; 51: 761-766
• 35 Starr P, Klein-Schwartz W, Spiller H. et al. Incidence and onset of delayed seizures after overdoses of extended-release bupropion. Am J Emerg Med. 2009; 27: 911-915
• 36 Spiller HA, Bosse GM, Beuhler M. et al. Unintentional ingestion of bupropion in children. J Emerg Med. 2010; 38: 332-336
• 37 Shepherd G. Adverse effects associated with extra doses of bupropion. Pharmacotherapy 2005; 25: 1378-1382
• 38 Balit CR, Lynch CN, Isbister GK. Bupropion poisoning: A case series. Med J Aust. 2003; 178: 61-63
• 39 Spiller HA, Ramoska EA, Krenzelok EP. et al. Bupropion overdose: A 3-year multi-center retrospective analysis. Am J Emerg Med. 1994; 12: 43-45
• 40 Beuhler MC, Spiller HA, Sasser HC. The outcome of unintentional pediatric bupropion ingestions: A NPDS database review. J Med Toxicol 2010; 6: 4-8
• 41 Belson MG, Kelley TR. Bupropion exposures: Clinical manifestations and medical outcome. J Emerg Med. 2002; 23: 223-230
• 42 Pesola GR, Avasarala J. Bupropion seizure proportion among new-onset generalized seizures and drug related seizures presenting to an emergency department. J Emerg Med. 2002; 22: 235-239
• 43 Wooltorton E. Bupropion (Zyban, Wellbutrin SR): Reports of deaths, seizures, serum sickness. CMAJ 2002; 166: 68
• 44 Lewis JC, Sutter ME, Albertson TE. et al. An 11-year review of bupropion insufflations exposures in adults reported to the California Poison Control System. Clin Toxicol (Phila) 2014; 52: 969-972
• 45 Dunner DL, Zisoo S, Billow AA. et al. A prospective safety surveillance study for bupropion sustained-release in the treatment of depression. J Clin Psychiatry. 1998; 59: 366-373
• 46 Johnston JA, Lineberry CG, Ascher JA. et al. A 102-center prospective study of seizure in association with bupropion. J Clin Psychiatry. 1991; 52: 450-456
• 47 Alper K, Schwartz KA, Kolts RL. et al. Seizure incidence in psychopharmacological clinical trials: An analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry. 2007; 62: 345-354
• 48 Kabuto H, Yokoi I, Takei M. et al. The anticonvulsant effect of citalopram on El mice, and the levels of tryptophan and tyrosine and their metabolites in the brain. Neurochem Res. 1994; 19: 463-467
• 49 Fischer W, Müller M. Pharmacological modulation of central monoaminergic systems and influence on the anticonvulsant effectiveness of standard antiepileptics in maximal electroshock seizure. Biomed Biochim Acta. 1988; 47: 631-645
• 50 Vermoesen K, Massie A, Smolders I. et al. The antidepressants citalopram and reboxetine reduce seizure frequency in rats with chronic epilepsy. Epilepsia 2012; 53: 870-878
• 51 Clinckers R, Smolders I, Meurs A. et al. Anticonvulsant action of GBR-12909 and citalopram against acute experimentally induced limbic seizures. Neuropharmacology 2004; 47: 1053-1061
• 52 Payandemehr B, Bahremand A, Rahimian R. et al. 5-HT(3) receptor mediates the dose-dependent effects of citalopram on pentylenetetrazole-induced clonic seizure in mice: involvement of nitric oxide. Epilepsy Res. 2012; 101: 217-227
• 53 Kelly CA, Dhaun N, Laing WJ. et al. Comparative toxicity of citalopram and the newer antidepressants after overdose. J Toxicol Clin Toxicol. 2004; 42: 67-71
• 54 Klein-Schwartz W, Benson BE, Lee SC. et al. Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children. Clin Toxicol (Phila) 2012; 50: 418-423
• 55 Hayes BD, Klein-Schwartz W, Clark RF. et al. Comparison of toxicity of acute overdoses with citalopram and escitalopram. J Emerg Med. 2010; 39: 44-48
• 56 Waring WS, Gray JA, Graham A. Predictive factors for generalized seizures after deliberate citalopram overdose. Br J Clin Pharmacol. 2008; 66: 861-865
• 57 Yilmaz Z, Ceschi A, Rauber-Lüthy C. et al. Escitalopram causes fewer seizures in human overdose than citalopram. Clin Toxicol (Phila) 2010; 48: 207-212
• 58 Personne M, Persson H, Sjöberg G. Picture of poisoning in citalopram overdose. Convulsions and ECG symptoms can occur. Lakartidningen 1997; 94: 1603-1604
• 59 Iskandar JW, Schmidley JW, Sharma TR. Citalopram-induced seizures in a healthy adult taking an FDA-approved dosage: a case report. Prim Care Companion CNS Disord 2011; 13: PCC.10101113
• 60 Specchio LM, Iudice A, Specchio N. et al. Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol. 2004; 27: 133-136
• 61 Kühn KU, Quednow BB, Thiel M. et al. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: A prospective study with three different antidepressants. Epilepsy Behav. 2003; 4: 674-679
• 62 Favale E, Audenino D, Cocito L. et al. The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis. Seizure 2003; 12: 316-318
• 63 Hovorka J, Herman E, Nemcová I. Treatment of interictal depression with citalopram in patients with epilepsy. Epilepsy Behav. 2000; 1: 444-447
• 64 Peterson SL, Trzeciakowski St JP, Mary JS. Chronic but not acute treatment with antidepressants enhances the electroconvulsive seizure response in rats. Neuropharmacology 1985; 24: 941-946
• 65 Koella WP, Glatt A, Klebs K. et al. Epileptic phenomena induced in the cat by the antidepressants maprotiline, imipramine, clomipramine, and amitriptyline. Biol Psychiatry. 1979; 14: 485-497
• 66 Trimble M, Anlezark G, Meldrum B. Seizure activity in photosensitive baboons following antidepressant drugs and the role of serotoninergic mechanisms. Psychopharmacology (Berl) 1977; 51: 159-164
• 67 Ohno Y, Sofue N, Imaoku T. et al. Serotonergic modulation of absence-like seizures in groggy rats: A novel rat model of absence epilepsy. J Pharmacol Sci. 2010; 114: 99-105
• 68 Cowe L, Lloyd DJ, Dawling S. Neonatal convulsions caused by withdrawal from maternal clomipramine. Br Med J (Clin Res Ed) 1982; 284: 1837-1838
• 69 The Clomipramine Collaborative Study Group . Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1991; 48: 730-738
• 70 Brodkin ES, McDougle CJ, Naylor ST. et al. Clomipramine in adults with pervasive developmental disorders: A prospective open-label investigation. J Child Adolesc Psychopharmacol 1997; 7: 109-121
• 71 Lewis MH, Bodfish JW, Powell SB. et al. Clomipramine treatment for self-injurious behavior of individuals with mental retardation: A double-blind comparison with placebo. Am J Ment Retard. 1996; 100: 654-665
• 72 DeToledo JC, Haddad H, Ramsay RE. Status epilepticus associated with the combination of valproic acid and clomipramine. Ther Drug Monit. 1997; 19: 71-73
• 73 Sakakihara Y, Oka A, Kubota M. et al. Reduction of seizure frequency with clomipramine in patients with complex partial seizures. Brain Dev. 1995; 17: 291-293
• 74 Garber HJ, McGonigle JJ, Slomka GT. et al. Clomipramine treatment of stereotypic behaviors and self-injury in patients with developmental disabilities. J Am Acad Child Adolesc Psychiatry. 1992; 31: 1157-1160
• 75 Yan QS, Dailey JW, Steenbergen JL. et al. Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): A microinjection study. Brain Res. 1998; 780: 199-209
• 76 Krijzer F, Snelder M, Bradford D. Comparison of the (pro)convulsive properties of fluvoxamine and clovoxamine with eight other antidepressants in an animal model. Neuropsychobiology 1984; 12: 249-254
• 77 Escorihuela RM, Boix F, Corda MG. et al. Chronic but not acute antidepressant treatment increases pentetrazol-induced convulsions in mice. J Pharm Pharmacol. 1989; 41: 143-144
• 78 Preskorn SH, Fast GA. Tricyclic antidepressant-induced seizures and plasma drug concentration. J Clin Psychiatry. 1992; 53: 160-162
• 79 Wedin GP, Oderda GM, Klein-Schwartz W. et al. Relative toxicity of cyclic antidepressants. Ann Emerg Med. 1986; 15: 797-804
• 80 Wroblewski BA, Joseph AB, Cornblatt RR. Antidepressant pharmacotherapy and the treatment of depression in patients with severe traumatic brain injury: A controlled, prospective study. J Clin Psychiatry. 1996; 57: 582-587
• 81 Krakowski AJ. Treatment of severe depression with desipramine: long-term trial and follow-up. Dis Nerv Syst 1964; 25: 739-745
• 82 Pineda MR, Russell SC. The use of a tricyclic antidepressant in epilepsy. Dis Nerv Syst 1974; 35: 322-323
• 83 Sun XY, Zhang L, Wei CX. et al. Characterization of the anticonvulsant activity of doxepin in various experimental seizure models in mice. Pharmacol Rep. 2009; 61: 245-251
• 84 Luchins DJ, Oliver AP, Wyatt RJ. Seizures with antidepressants: an in vitro technique to assess relative risk. Epilepsia 1984; 25: 25-32
• 85 Ojemann LM, Friel PN, Trejo WJ. et al. Effect of doxepin on seizure frequency in depressed epileptic patients. Neurology 1983; 33: 646-648
• 86 Citraro R, Leo A, De Fazio P. et al. Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy. Br J Pharmacol. 2015; 172: 3177-3188
• 87 Pellicciari A, Balzarro B, Scaramelli A. et al. Generalized tonic-clonic seizure secondary to duloxetine poisoning: A short report with favorable outcome. Neurotoxicology 2012; 33: 189-190
• 88 Grover CA, Flaherty B, Lung D. et al. Significant toxicity in a young female after low-dose tricyclic antidepressant ingestion. Pediatr Emerg Care. 2012; 28: 1066-1069
• 89 Qadir A, Haider N. Duloxetine withdrawal seizure. Psychiatry (Edgmont) 2006; 3: 10
• 90 Melani F, Rosati E, Chiocchetti B. et al. Antidepressant-associated myoclonic status in a patient with symptomatic generalized epilepsy: Does risk occur with therapeutic doses?. Epilepsy Behav 2009; 14: 681-683
• 91 Van Gorp F, Whyte IM, Isbister GK. Clinical and ECG effects of escitalopram overdose. Ann Emerg Med. 2009; 54: 404-408
• 92 Ismaĭlova K, Miadzhidi MB. Study on the effect of selective serotonin reuptake inhibitor fluoxetine on seizures and inborn behavior of rats with different phenotype of the nervous system. Zh Vyssh Nerv Deiat Im I P Pavlova 2012; 62: 745-752
• 93 Igelström KM, Heyward PM. The antidepressant drug fluoxetine inhibits persistent sodium currents and seizure-like events. Epilepsy Res. 2012; 101: 174-181
• 94 Kecskeméti V, Rusznák Z, Riba P. et al. Norfluoxetine and fluoxetine have similar anticonvulsant and Ca2+ channel blocking potencies. Brain Res Bull. 2005; 67: 126-132
• 95 Pericić D, Lazić J, Svob Strac D. Anticonvulsant effects of acute and repeated fluoxetine treatment in unstressed and stressed mice. Brain Res. 2005; 1033: 90-95
• 96 Wada Y, Shiraishi J, Nakamura M. et al. Prolonged but not acute fluoxetine administration produces its inhibitory effect on hippocampal seizures in rats. Psychopharmacology (Berl) 1995; 118: 305-309
• 97 Yan QS, Jobe PC, Dailey JW. Evidence that a serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Eur J Pharmacol. 1994; 252: 105-112
• 98 Prendiville S, Gale K. Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats. Epilepsia 1993; 34: 381-384
• 99 Suchard JR. Fluoxetine overdose-induced seizure. West J Emerg Med 2008; 9: 154-156
• 100 Braitberg G, Curry SC. Seizure after isolated fluoxetine overdose. Ann Emerg Med. 1995; 26: 234-237
• 101 Riddle MA, Brown N, Dzubinski D. et al. Fluoxetine overdose in an adolescent. J Am Acad Child Adolesc Psychiatry. 1989; 28: 587-588
• 102 Phillips S, Brent J, Kulig K. et al. Fluoxetine versus tricyclic antidepressants: a prospective multicenter study of antidepressant drug overdoses. The Antidepressant Study Group. J Emerg Med. 1997; 15: 439-445
• 103 Levine R, Kenin M, Hoffman JS. et al. Grand mal seizures associated with the use of fluoxetine. J Clin Psychopharmacol. 1994; 14: 145-146
• 104 Murthy R, Newton K, Qureshi J. The association of fluoxetine with seizures. J Psychopharmacol. 1994; 8: 187-188
• 105 Oke A, Adhiyaman V, Aziz K. et al. Dose-dependent seizure activity associated with fluoxetine therapy. QJM 2001; 94: 113-114
• 106 Ware MR, Stewart RB. Seizures associated with fluoxetine therapy. DICP 1989; 23: 428
• 107 Weber JJ. Seizure activity associated with fluoxetine therapy. Clin Pharm. 1989; 8: 296-298
• 108 Hargrave R, Martinez D, Bernstein AJ. Fluoxetine-induced seizures. Psychosomatics 1992; 33: 236-239
• 109 Jain U, Birmaher B, Garcia M. et al. Fluoxetine in children and adolescents with mood disorders: A chart review of efficacy and adverse effects. J Child Adolesc Psychopharmacol 1992; 2: 259-265
• 110 Meador KJ. Seizure reduction with fluoxetine in Dravet syndrome. Epilepsy Behav Case Rep 2014; 2: 54-56
• 111 Thomé-Souza MS, Kuczynski E, Valente KD. Sertraline and fluoxetine: Safe treatments for children and adolescents with epilepsy and depression. Epilepsy Behav. 2007; 10: 417-425
• 112 Favale E, Rubino V, Mainardi P. et al. Anticonvulsant effect of fluoxetine in humans. Neurology 1995; 45: 1926-1927
• 113 Gigli GL, Diomedi M, Troisi A. et al. Lack of potentiation of anticonvulsant effect by fluoxetine in drug-resistant epilepsy. Seizure 1994; 3: 221-224
• 114 Steel CM, O’Duffy J, Brown SS. Clinical effects and treatment of imipramine and amitriptyline poisoning in children. Br Med J. 1967; 3: 663-667
• 115 Jørgensen F. Imipramine poisoning. Ugeskr Laeger. 1964; 126: 591-594
• 116 Hamed M, Mitchell H, Clow DJ. Hyponatraemic convulsion associated with desmopressin and imipramine treatment. BMJ 1993; 306: 1169
• 117 Brown D, Winsberg BG, Bialer I. et al. Imipramine therapy and seizures: three children treated for hyperactive behaviour disorders. Am J Psychiatry. 1973; 130: 210-212
• 118 Hurst DL. The use of imipramine in minor motor seizures. Pediatr Neurol. 1986; 2: 13-17
• 119 Fromm GH, Wessel HB, Glass JD. et al. Imipramine in absence and myoclonic-astatic seizures. Neurology 1978; 28: 953-957
• 120 Payandemehr B, Bahremand A, Ebrahimi A. et al. Protective effects of lithium chloride on seizure susceptibility: Involvement of α2-adrenoceptor. Pharmacol Biochem Behav. 2015; 133: 37-42
• 121 Macedo DS, Santos RS, Belchior LD. et al. Effect of anxiolytic, antidepressant, and antipsychotic drugs on cocaine-induced seizures and mortality. Epilepsy Behav. 2004; 5: 852-856
• 122 Askenasi R, Linkowski P, Leemen M. Seizures due to lithium intoxication. Nouv Presse Med 1981; 10: 3481-3482
• 123 Amdisen A. Clinical features and management of lithium poisoning. Med Toxicol Adverse Drug Exp 1988; 3: 18-32
• 124 De Haro L, Roelandt J, Pommier P. et al. Aetiologies of lithium overdose: 10-year experience of Marseille poison centre. Ann Fr Anesth Reanim. 2003; 22: 514-519
• 125 Grueneberger EC, Maria Rountree E, Baron Short E. et al. Neurotoxicity with therapeutic lithium levels: a case report. J Psychiatr Pract. 2009; 15: 60-63
• 126 Sacristan JA, Iglesias C, Arellano F. et al. Absence seizures induced by lithium: Possible interaction with fluoxetine. Am J Psychiatry. 1981; 148: 146-147
• 127 Julius SC, Brenner RP. Myoclonic seizures with lithium. Biol Psychiatry. 1987; 22: 1184-1190
• 128 Massey EW, Foler WN. Seizures activated by therapeutic levels of lithium carbonate. South Med J. 1984; 77: 1173-1175
• 129 Larousse C, Spreux A, Resche F. Epileptic seizure at the beginning of lithium carbonate treatment. Therapie 1980; 35: 749-750
• 130 Demers R, Lukesh R, Prichard J. Convulsion during lithium therapy. Lancet 1970; 7667: 315-316
• 131 Baldessarini RJ, Stephens JH. Lithium carbonate for affective disorders. I. Clinical pharmacology and toxicology. Arch Gen Psychiatry. 1970; 22: 72-77
• 132 Helmchen H, Kanowski S. EEG changes under Lithium (Li) treatment. Electroencephalogr Clin Neurophysiol. 1970; 30: 269
• 133 Jus A, Villeneuve A, Gautier J. et al. Influence of lithium carbonate on patients with temporal epilepsy. Can Psychiatr Assoc J. 1973; 18: 77
• 134 Erwin CW, Gerber CJ, Morrison SD. et al. Lithium carbonate and convulsive disorders. Arch Gen Psychiatry. 1973; 28: 646-648
• 135 Shukla S, Mukherjee S, Decina P. Lithium in the treatment of bipolar disorders associated with epilepsy: An open study. J Clin Psychopharmacol. 1988; 8: 201-203
• 136 Berling I, Isbister GK. Mirtazapine overdose is unlikely to cause major toxicity. Clin Toxicol (Phila) 2014; 52: 20-24
• 137 Kühn KU, Quednow BB, Thiel M. et al. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: A prospective study with three different antidepressants. Epilepsy Behav. 2003; 4: 674-679
• 138 Goldina OA, Tepliakov VG, Demurov EA. et al. Effect of benzamide derivatives on convulsions induced by the toxic action of oxygen in rats. Buill Eksp Biol Med 1987; 104: 469-471
• 139 Bisserbe JC, Lépine JP. Moclobemide in social phobia: A pilot open study. GRP Group. Groupe de Recherche en Pyschopharmacologie. Clin Neuropharmacol. 1994; 17: S88-S94
• 140 Lipper B, Bell A, Gaynor B. Recurrent hypotension immediately after seizures in nortriptyline overdose. Am J Emerg Med. 1994; 12: 452-453
• 141 Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2007; 1: CD000031
• 142 Ago J, Ishikawa T, Matsumoto N. et al. Epileptiformic activity induced by antidepressants in amygdala-kindled rats. Europ J Pharmacol 2007; 560: 23-28
• 143 Barbey JT, Roose SP. SSRI safety in overdose. J Clin Psychiatry 1998; 59 (Suppl. 15) 42-48
• 144 Taniguchi G, Miyajima M, Watanabe M. et al. Nonconvulsive status epilepticus in the elderly associated with newer antidepressants used at therapeutic doses: A report of three cases. Epilepsy Behav Case Rep 2015; 3: 8-11
• 145 Citraro R, Leo A, Aiello R. et al. Comparative analysis of the treatment of chronic antipsychotic drugs on epileptic susceptibility in genetically epilepsy-prone rats. Neurotherapeutics 2015; 12: 250-262
• 146 Eyer F, Pfab R, Felgenhauer N. et al. Clinical and analytical features of severe suicidal quetiapine overdoses–a retrospective cohort study. Clin Toxicol (Phila) 2011; 49: 846-853
• 147 Ngo A, Ciranni M, Olson KR. Acute quetiapine overdose in adults: A 5-year retrospective case series. Ann Emerg Med. 2008; 52: 541-547
• 148 Balit CR, Isbister GK, Hackett LP. et al. Quetiapine poisoning: A case series. Ann Emerg Med. 2003; 42: 751-758
• 149 Zhang C, Agius M, Zaman R. Case report of a patient with bipolar disorder – migraines and epilepsy. Psychiatr Danub 2012; 24 (Suppl. 01) 109-111
• 150 Barceló B, Yates C, Castayaner B. et al. Delayed seizures after topiramate, venlafaxine and quetiapine overdose. Med Clin (Barc) 2010; 135: 191-192
• 151 Centorrino F, Price BH, Tuttle M. et al. EEG abnormalities during treatment with typical and atypical antipsychotics. Am J Psychiatry. 2002; 159: 109-115
• 152 Gupta M, Kulkarni SK. Studies on anticonvulsant actions of L-deprenyl. Ind J Exp Biol 2000; 38: 332-337
• 153 Kobayashi T, Saito N, Suda S. et al. Pharmacoresistant convulsions and visual hallucinations around two weeks after selegiline overdose: A case report. Pharmacopsychiatry 2011; 44: 346-347
• 154 Sitges M, Gómez CD, Aldana BI. Sertraline reduces IL-1β and TNF-α mRNA expression and overcomes their rise induced by seizures in the rat hippocampus. PLoS One 2014; 9: e111665
• 155 Faingold CL, Randall M. Effects of age, sex, and sertraline administration on seizure-induced respiratory arrest in the DBA/1 mouse model of sudden unexpected death in epilepsy (SUDEP). Epilepsy Behav. 2013; 28: 78-82
• 156 Isbister GK, Bowe SJ, Dawson A. et al. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol. 2004; 42: 277-285
• 157 Goldstein L, Barker M, Segall F. et al. Seizure and transient SIADH associated with sertraline. Am J Psychiatry. 1996; 153: 732
• 158 Shubrata KS, Narayanaswamy JC, Viswanath B. et al. Sertraline-induced hyponatremia and seizures in old age. J Neuropsychiatry Clin Neurosci 2012; 24: E47
• 159 Raju GV, Kumar TC, Khanna S. Seizures associated with sertraline. Can J Psychiatry. 2000; 45: 491
• 160 Saraf M, Schrader G. Seizure associated with sertraline. Aust N Z J Psychiatry 1999; 33: 944-945
• 161 McDougle CJ, Brodkin ES, Naylor ST. et al. Sertraline in adults with pervasive developmental disorders: A prospective open-label investigation. J Clin Psychopharmacol. 1998; 18: 62-66
• 162 Kanner AM, Kozak AM, Frey M. The use of sertraline in patients with epilepsy: is it safe?. Epilepsy Behav 2000; 1: 100-105
• 163 Tagashira E, Hiramori T, Urano T. et al. Specific action of tranylcypromine to precipitate barbital withdrawal convulsions. Psychopharmacology (Berl) 1982; 77: 101-114
• 164 Vanpee D, Laloyaux P, Gillet JB. Seizure and hyponatraemia after overdose of trazadone. Am J Emerg Med. 1999; 17: 430-431
• 165 Baughan E, Jawad SS. Effect of overdose of trazodone. BMJ 1992; 304: 1114
• 166 Balestrieri G, Cerudelli B, Ciaccio S. et al. Hyponatraemia and seizure due to overdose of trazodone. BMJ 1992; 304: 686
• 167 Bowdan ND. Seizure possibly caused by trazodone HCl. Am J Psychiatry. 1983; 140: 642
• 168 Tasini M. Complex partial seizures in a patient receiving trazodone. J Clin Psychiatry. 1986; 47: 318-319
• 169 Santos Jr JG, Do Monte FH, Russi M. et al. Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats. Braz J Med Biol Res. 2002; 35: 469-472
• 170 Whyte IM, Dawson AH, Buckley NA. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. QJM 2003; 96: 369-374
• 171 Thundiyil JG, Kearney TE, Olson KR. Evolving epidemiology of drug-induced seizures reported to a Poison Control Center System. J Med Toxicol 2007; 3: 15-19
• 172 Touchet BK, Brahm NC, Fox MD. A case of seizure activity associated with a therapeutic dose of venlafaxine. Prim Care Companion CNS Disord 2013; 15: PCC.12101479
• 173 Meyer I, Frank D, Janssens U. A case of venlafaxine-induced syndrome of inappropriate ADH secretion (SIADH)-treatment with tolvaptan. Dtsch Med Wochenschr. 2012; 137: 1096-1099
• 174 Acker EC, Sinclair EA, Beardsley AL. et al. Acute vilazodone toxicity in a pediatric patient. J Emerg Med. 2015; 89: 284-286
• 175 Carstairs SD, Griffith EA, Alayin T. et al. Recurrent seizure activity in a child after acute vilazodone ingestion. Ann Emerg Med. 2012; 60: 819-820
• 176 McKean J, Watts H, Mokszycki R. Breakthrough seizures after starting vilazodone for depression. Pharmacotherapy 2015; 35: e6-e8
• 177 Kotsopoulos IA, van Merode T, Kessels FG. et al. Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures. Epilepsia 2002; 43: 1402-1409
• 178 Hyde TM, Weinberger DR. Seizures and schizophrenia. Schizophr Bull. 1997; 23: 611-622
• 179 Swinkels WA, Kuyk J, van Dyck R. et al. Psychiatric comorbidity in epilepsy. Epilepsy Behav. 2005; 7: 37-50
• 180 Gelisse P, Samuelian JC, Genton P. Is schizophrenia a risk factor for epilepsy or acute symptomatic seizures?. Epilepsia 1999; 40: 1566-1571
• 181 Bloechliger M, Ceschi A, Rüegg S. et al. Risk of seizures associated with antidepressant use in patients with depressive disorder: Follow-up study with a nested case-control analysis using the Clinical Practice Research Datalink. Drug Saf. 2016; 39: 307-321
• 182 Bergmann F, Bleich S, Wischer S. et al. Seizure and cardiac arrest during bupropion SR treatment. J Clin Psychopharmacol. 2002; 22: 630-631
• 183 Pisani F, Oteri G, Costa C. et al. Effects of psychotropic drugs on seizure threshold. Drug Saf. 2002; 25: 91-110
• 184 Steinert T, Baier H, Fröscher W. et al. Epileptic seizures under treatment with antidepressants and neuroleptics. Fortschr Neurol Psychiat. 2011; 79: 138-143
• 185 Mula M, Schmitz B. Depression in epilepsy: Mechanisms and therapeutic approach. Ther Adv Neurol Disord 2009; 2: 337-344
• 186 Okazaki M, Adachi N, Ito M. et al. One-year seizure prognosis in epilepsy patients treated with antidepressants. Epilepsy Behav. 2011; 22: 331-335
• 187 Ojemann LM, Baugh-Bookman C, Dudley DL. Effect of psychotropic medications on seizure control in patients with epilepsy. Neurology 1987; 37: 1525-1527
• 188 Barry JJ, Ettinger AB, Friel P. et al. Consensus statement: The evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav. 2008; 13 (Suppl. 01) S1-S29
• 189 Kerr MP, Mensah S, Besag F. et al. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. Epilepsia 2011; 52: 2133-2138
• 190 Cardamone L, Salzberg MR, O’Brien TJ. et al. Antidepressant therapy in epilepsy: Can treating the comorbidities affect the underlying disorder?. Br J Pharmacol 2013; 168: 1531-1554
• 191 Ojong M, Allen SN. Treatment depression in patients with epilepsy. US Pharm 2012; 37: 29-32
• 192 Hanekamp BB, Zijlstra JG, Tulleken JE. et al. Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: A case report. Neth J Med. 2005; 63: 316-318
• 193 Twardowschy CA, Bertolucci CB, Gracia CM. et al. Severe hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with fluoxetine: Case report. Arg Neuropsiquiatr 2006; 64: 142-145